The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 1,356 | 2,860 |
| Depreciation and accretion | 531 | 1,030 |
| Amortization of intangible assets | 55 | 104 |
| Amortization of major maintenance costs for reaction-based plants | 18 | 31 |
| Other amortization expense | 56 | 114 |
| Impairment of assets other than goodwill | 17 | 21 |
| Equity in income of unconsolidated affiliates | 90 | 186 |
| Distributions received from unconsolidated affiliates attributable to earnings | 91 | 189 |
| Net losses (gains) attributable to asset sales and related matters | 4 | 9 |
| Deferred income tax expense (benefit) | -17 | 16 |
| Change in fair market value of derivative instruments | -34 | 10 |
| Non-cash expense related to long-term operating leases (see note 17) | 27 | 55 |
| Net effect of changes in operating accounts (see note 18) | 322 | -153 |
| Other operating activities | -14 | 7 |
| Net cash flow provided by operating activities | 1,738 | 4,375 |
| Capital expenditures | 4,319 | - |
| Investments in unconsolidated affiliates | 0 | 1 |
| Capital expenditures | - | 2,361 |
| Distributions received from unconsolidated affiliates attributable to the return of capital | 21 | 35 |
| Proceeds from asset sales and other matters | 6 | 15 |
| Other investing activities | 4 | 9 |
| Net cash flow used in investing activities | -1,935 | -2,321 |
| Borrowings under debt agreements | 21,469 | 49,565 |
| Repayments of debt | 20,629 | 48,720 |
| Debt issuance costs | 4 | 25 |
| Monetization of interest rate derivative instruments | 0 | -14 |
| Cash distributions paid to common unitholders (see note 8) | 1,180 | 2,319 |
| Cash payments made in connection with distribution equivalent rights | 11 | 22 |
| Cash distributions paid to noncontrolling interests | 29 | 39 |
| Cash contributions from noncontrolling interests | 0 | 5 |
| Repurchase of common units under 2019 buyback program | 80 | 170 |
| Acquisition of noncontrolling interests | 0 | 0 |
| Other financing activities | -3 | -85 |
| Net cash flow used in financing activities | -467 | -1,796 |
| Net change in cash and cash equivalents, including restricted cash | -664 | 258 |
| Cash and cash equivalents at beginning of period | 838 | - |
| Cash and cash equivalents at end of period | 432 | - |
ENTERPRISE PRODUCTS PARTNERS L.P. (EPDU)
ENTERPRISE PRODUCTS PARTNERS L.P. (EPDU)